Tag Archives: Celgene Corporation

Whistleblower Lawsuit Related to Cancer Drug Marketing Leads to Celgene Paying $280 Million

Celgene Corporation, a biotech company based in New Jersey, will pay out $280 million to settle claims that it cited uses not approved by the U.S. Food and Drug Administration (FDA) in promotion of its cancer treatment drugs Thalomid and Fevlimid. According to Judge George H. King, the plaintiff “provided sufficient evidence” that the corporation […]

By Steve Kardell | Published November 16, 2017 | Posted in Whistleblower Litigation | Tagged Celgene Corporation, provided sufficient evidence, Thalomid and Fevlimid | Comments Off on Whistleblower Lawsuit Related to Cancer Drug Marketing Leads to Celgene Paying $280 Million

Sign Up To Hear More From Steve

Sign Up Now
For Email Marketing you can trust.
Honors
CORPORATE INTERNAL INVESTIGATION & WHISTLEBLOWER LAW LINKS
LOCATION
- Steve Kardell
  
  4514 Cole Ave
  #600
  
  Dallas, Texas 75205
  Phone: 214-306-8045
  Fax: 469-729-9926
READ ARTICLE
FOLLOW US

Testimonials

Reaching out to Steve Kardell was the best decision I made. His ability to provide immediate insight and direction was very powerful, and a huge relief during a very stressful… read more
Steve Kardell was terrific in representing me in some very adversarial discussions with Citigroup and also later represented me in my testimony before the Financial Crisis Inquiry Commission. --Richard Bowen,… read more
As a result of a wrongful termination, I engaged Steve Kardell as legal counsel. Steve took charge of a difficult situation for me and defended my case with my former… read more
I wanted to take the time to write to let you know that I am very pleased with the performance, support, professionalism and determination of Mr. Kardell. Obtaining Mr. Kardell… read more

Tag Archives: Celgene Corporation

Whistleblower Lawsuit Related to Cancer Drug Marketing Leads to Celgene Paying $280 Million

Contact Form

Quick Contact Form